Manufacturing

The core architecture of a chimeric antigen receptor relies on a single-chain variable fragment linked to intracellular signaling components that ignite T cell proliferation. As the pharmaceutical industry entered the second half of the current decade, the shift from experimental novelty to

Singapore’s integration into European testing networks ensures that biological drugs manufactured in the city-state meet the world's most stringent laboratory standards. This development signifies a broader shift in the city-state's role, transitioning from a localized regulatory body into a

Researchers at Birjand University of Medical Sciences are targeting the unique mechanical requirements of the knee by leveraging the dense native collagen found in camels. This specific focus on camel-derived tissue addresses one of the most persistent challenges in orthopedic medicine: the repair

The shift by Cellectis to prioritize APOC3 and PCSK9 programs illustrates a broader movement toward genomic modulation for long-lasting treatment of chronic illnesses. This strategic pivot marks a departure from the industry’s early fixation on ultra-rare genetic disorders, signaling a newfound

The Multifors 3 platform revolutionizes documentation by retaining hardware setups and cascade configurations as part of its core reproducibility strategy. This innovative approach to bench-scale bioprocessing arrives at a time when the pharmaceutical industry faces immense pressure to accelerate

Modern hydrogel designs mimic the natural environment of living tissue by maintaining a moisture content of roughly 90 percent to prevent cell death and scarring. This fundamental shift in wound management comes at a time when traditional methods are increasingly viewed as insufficient for the